ARQT — Arcutis Biotherapeutics
Median target
$36.5
calls from the last 12 months
Implied return
+14.1%
median target vs. price
Coverage
7 analysts · 9 calls
updated in the last 12 months
Consensus
6/1/0+6 net
Buy / Hold / Sell
Which analysts are behind ARQT's consensus?
See every current rating, price target and the analysts' track records for Arcutis Biotherapeutics — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 7 analysts with calls on ARQT updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
ARQT elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-11-04 | Insiders | Matsuda MasaruEVP, Chief Legal Officer | Insider sale | 40.0K sh @ $34.32 · planned trade | $1.4M |
| 2026-11-02 | Insiders | Watanabe ToddSee Remarks | Insider sale | 4.4K sh @ $31.86 | $139K |
| 2026-11-02 | Insiders | Matsuda MasaruEVP, Chief Legal Officer | Insider sale | 1.2K sh @ $31.86 · planned trade | $39K |
| 2026-11-02 | Insiders | Burnett PatrickEVP, Chief Medical Offic | Insider sale | 943 sh @ $31.86 | $30K |
| 2026-10-15 | Insiders | Welgus Howard G.Director | Insider sale | 4.7K sh @ $26.93 · planned trade | $127K |
| 2026-09-16 | Insiders | Matsuda MasaruOfficer | Insider sale | 3.7K sh @ $25.00 · planned trade | $92K |
| 2026-09-15 | Insiders | Welgus Howard G.Director | Insider sale | 4.7K sh @ $24.18 · planned trade | $114K |
| 2026-09-08 | Insiders | Matsuda MasaruOfficer | Insider sale | 10.0K sh @ $25.03 · planned trade | $250K |
| 2026-03-03 | Congress | Gilbert CisnerosCA-CA39 | Purchase | since trade +35.6%, vs market +24.4% | $1K–$15K |
| 2025-12-11 | Congress | Gilbert CisnerosCA-CA39 | Sale | since trade +8.6%, vs market +1.5% | $1K–$15K |
More: congressional trades on ARQT · insider activity · executive branch · trending